Viewing Study NCT00005634


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-28 @ 12:06 AM
Study NCT ID: NCT00005634
Status: COMPLETED
Last Update Posted: 2013-06-19
First Post: 2000-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module